Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

Primarily lower sales as well as a steep fall in gross margins led to the weak financial performance of the company during ...

Deepak Nitrite for the December quarter is expected to post a steady performance with Q3 PAT declining 5.9 per cent on-year.

CorVel (NASDAQ:CRVL – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. CorVel Price Performance ...

As part of its previously-announced strategic review ... our innovation and focused the business on the areas where we have a proven right to win." "This quarter's results are proof that our ...

The Small Business Administration’s 7(a) loan program lost hundreds of millions of dollars in 2024, according to documents ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Western Forest Products Inc. ( OTCPK:WFSTF) Q4 2024 Earnings Conference Call February 14, 2025 12:00 PM ET Steven Hofer - President and CEO Glenn Nontell - CFO Bruce Alexander - SVP of Sales, ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation"), one of Canada's largest logistics providers today reported its financial ...